SCHEMBL8307827

SCHEMBL8307827

O/N=C/c1cncc(-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
FDPS P14324 3/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ATM Q13315 1/20 0.41
CNR1 P21554 1/20 0.40
RIPK1 Q13546 1/20 0.40
CYP2A6 P11509 3/20 0.40
CYP3A4 P08684 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PTGS2 P35354 2/20 0.39
DYRK3 O43781 1/20 0.39
DYRK1A Q13627 1/20 0.39
DYRK2 Q92630 1/20 0.39
DYRK1B Q9Y463 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307833 1.00 MKNK1 (0.44) MKNK1MKNK2GSK3AGSK3BFDPS
SCHEMBL28881266 0.83 PIP4K2B (0.45) ALDH1A1RIPK1PTGS2FGF23CYP11B1
SCHEMBL28881554 0.82 CYP11B2 (0.47) GSK3AGSK3BRIPK1CYP3A4MEN1
SCHEMBL29987414 0.82 CYP11B2 (0.47) GSK3AGSK3BRIPK1CYP3A4MEN1
SCHEMBL29986835 0.82 KMO (0.56) MKNK1MKNK2KDM4EALDH1A1L3MBTL1
SCHEMBL29987911 0.79 CYP11B2 (0.45) RIPK1CYP11B1CYP11B2
SCHEMBL28881564 0.79 CYP11B2 (0.45) RIPK1CYP11B1CYP11B2
SCHEMBL28881566 0.79 CYP11B2 (0.45) RIPK1CYP11B1CYP11B2
SCHEMBL28881247 0.79 CYP11B2 (0.42) ALDH1A1L3MBTL1ATMDYRK1ADYRK2
SCHEMBL29987430 0.79 CYP11B1 (0.46) CYP3A4DYRK3DYRK1ADYRK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed